Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca is cutting 700 jobs at its Macclesfield plant in the UK as part of a worldwide restructuring plan which will bring the loss of 3000 positions.
Subscribe to our email newsletter
The plant employs 2,500 people of whom 1,800 are in supply and manufacturing positions. The cuts will be made over the next three years. Despite the losses, the company insists that the site will still be integral to AstraZeneca’s global supply chain.
The UK drug maker faces several important patent expiries, and three late-stage pipeline drug failures have raised concerns about the company, prompting an efficiency drive.
Meanwhile, in Japan, AstraZeneca said that it would not reduce its business in the country, according to Reuters. Japan is AstraZeneca’s second-biggest market.